| Q34550965 | 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice. |
| Q47852679 | A Novel Neuroprotective Mechanism for Lithium That Prevents Association of the p75NTR-Sortilin Receptor Complex and Attenuates proNGF-Induced Neuronal Death In Vitro and In Vivo |
| Q45356351 | A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid. |
| Q27308971 | A macaque model of mesial temporal lobe epilepsy induced by unilateral intrahippocampal injection of kainic Acid |
| Q36156089 | A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator |
| Q48760543 | A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201–995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus |
| Q42006202 | Activation of group 2 metabotropic glutamate receptors reduces behavioral and electrographic correlates of pilocarpine induced status epilepticus |
| Q33542011 | Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system |
| Q48248567 | Activity-dependent regulation of alternative splicing patterns in the rat brain |
| Q24642922 | Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability |
| Q44873083 | Adenosine A2A receptor deficient mice are partially resistant to limbic seizures |
| Q36499746 | Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents? |
| Q34047643 | Altered expression and function of small-conductance (SK) Ca(2+)-activated K+ channels in pilocarpine-treated epileptic rats |
| Q35776880 | Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy |
| Q34604307 | Animal models of limbic epilepsies: what can they tell us? |
| Q42548702 | Anticonvulsant activity of new and potent inhibitors of nitric oxide synthase |
| Q42409348 | Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models |
| Q38974450 | Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going? |
| Q47825145 | Antimuscarinic-induced convulsions in fasted animals after food intake: evaluation of the effects of levetiracetam, topiramate and different doses of atropine. |
| Q48233177 | Anxiogenic-like profile of Wistar adult rats based on the pilocarpine model: an animal model for trait anxiety? |
| Q43971144 | Attenuating effects of melatonin on pilocarpine-induced seizures in rats |
| Q48016883 | Behavioral, electroencephalographic, and histopathologic effects of a neuropeptide isolated from Tityus serrulatus scorpion venom in rats |
| Q51544720 | Blockade of spreading depression in chronic epileptic rats: reversion by diazepam. |
| Q48292550 | Ca(v)1.2, Ca(v)1.3, and Ca(v)2.1 in the mouse hippocampus during and after pilocarpine-induced status epilepticus |
| Q33642642 | Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy |
| Q41553237 | Changes in Hippocampal Volume are Correlated with Cell Loss but Not with Seizure Frequency in Two Chronic Models of Temporal Lobe Epilepsy |
| Q90392461 | Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice |
| Q34459275 | Chronic deficit in the expression of voltage-gated potassium channel Kv3.4 subunit in the hippocampus of pilocarpine-treated epileptic rats |
| Q45999480 | Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. |
| Q24598903 | Cyclothiazide induces seizure behavior in freely moving rats |
| Q37000100 | Deficit of Kcnma1 mRNA expression in the dentate gyrus of epileptic rats. |
| Q48788737 | Different types of status epilepticus lead to different levels of brain damage in rats |
| Q37102095 | Differential changes in mGlu2 and mGlu3 gene expression following pilocarpine-induced status epilepticus: a comparative real-time PCR analysis |
| Q28377144 | Differential progression of Dark Neuron and Fluoro-Jade labelling in the rat hippocampus following pilocarpine-induced status epilepticus |
| Q33677979 | Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development |
| Q34446698 | Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice |
| Q36012054 | Does the Thalamo-Cortical Synchrony Play a Role in Seizure Termination? |
| Q33320921 | Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy |
| Q34015797 | Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans |
| Q88378201 | EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity |
| Q89817626 | Effects of Non-invasive, Targeted, Neuronal Lesions on Seizures in a Mouse Model of Temporal Lobe Epilepsy |
| Q48700702 | Effects of pilocarpine and kainate-induced seizures on N-methyl-D-aspartate receptor gene expression in the rat hippocampus |
| Q64096754 | Electroconvulsive Shock Enhances Responsive Motility and Purinergic Currents in Microglia in the Mouse Hippocampus |
| Q46061966 | Electroencephalography and behavior patterns during experimental status epilepticus |
| Q28259250 | Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy |
| Q73635218 | Epileptogenesis in immature rats following recurrent status epilepticus |
| Q37225136 | Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions |
| Q45001834 | Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. |
| Q45334833 | Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats. |
| Q36279135 | Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy |
| Q46740427 | Fish oil provides protection against the oxidative stress in pilocarpine model of epilepsy. |
| Q45070196 | Fos induction and persistence, neurodegeneration, and interneuron activation in the hippocampus of epilepsy-resistant versus epilepsy-prone rats after pilocarpine-induced seizures |
| Q90768175 | Functional responses of the hippocampus to hyperexcitability depend on directed, neuron-specific KCNQ2 K+ channel plasticity |
| Q47340618 | Heterozygous Gnal Mice Are a Novel Animal Model with Which to Study Dystonia Pathophysiology. |
| Q41983170 | High-frequency (80-500 Hz) oscillations and epileptogenesis in temporal lobe epilepsy |
| Q34328252 | Hippocampal desynchronization of functional connectivity prior to the onset of status epilepticus in pilocarpine-treated rats |
| Q27303313 | Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry |
| Q37102115 | Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats |
| Q50659294 | Impaired extinction of fear and maintained amygdala‐hippocampal theta synchrony in a mouse model of temporal lobe epilepsy |
| Q91810708 | Increased expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 after pilocarpine-induced status epilepticus in mice |
| Q36610296 | Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus |
| Q30457930 | Influence of aspirin on pilocarpine-induced epilepsy in mice |
| Q44438329 | Intact spatial memory in mice with seizure-induced partial lossof hippocampal pyramidal neurons |
| Q47945217 | LC-MS/MS imaging with thermal film-based laser microdissection |
| Q91414412 | Life and death in the hippocampus: What's bad? |
| Q43850163 | Limbic network interactions leading to hyperexcitability in a model of temporal lobe epilepsy |
| Q28369014 | Loss of NADPH diaphorase-positive neurons in the hippocampal formation of chronic pilocarpine-epileptic rats |
| Q42550870 | MK-801 augments pilocarpine-induced electrographic seizure but protects against brain damage in rats |
| Q45139560 | Malnutrition and REM-sleep deprivation modulate in rats the impairment of spreading depression by a single sub-convulsing dose of pilocarpine. |
| Q28083319 | Manganese-Enhanced MRI: Biological Applications in Neuroscience |
| Q37039816 | Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions |
| Q30494664 | Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice. |
| Q39832712 | Mild hypothermia pretreatment protects against pilocarpine-induced status epilepticus and neuronalapoptosis in immature rats |
| Q42597208 | Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome |
| Q38865854 | Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. |
| Q41597952 | Molecular pathogenesis of alcohol withdrawal seizures: the modified lipid-protein interaction mechanism |
| Q35556975 | Morphometric MRI alterations and postoperative seizure control in refractory temporal lobe epilepsy |
| Q43132098 | Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon-induced seizures |
| Q35008651 | Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. |
| Q42549975 | Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice |
| Q37987432 | Neurogenesis in the epileptic brain: a brief overview from temporal lobe epilepsy |
| Q43253697 | Neuroprotective action of FK-506 (tacrolimus) after seizures induced with pilocarpine: quantitative and topographic elemental analysis of brain tissue |
| Q44532210 | Neuroprotective activity of antazoline against neuronal damage induced by limbic status epilepticus |
| Q42761640 | Neurosteroidal modulation of in vitro epileptiform activity is enhanced in pilocarpine-treated epileptic rats. |
| Q42178322 | Non-linear classification of heart rate parameters as a biomarker for epileptogenesis |
| Q91194991 | Nonperiodic stimulation for the treatment of refractory epilepsy: Applications, mechanisms, and novel insights |
| Q28361763 | Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen |
| Q47446247 | Physical exercise alters the activation of downstream proteins related to BDNF-TrkB signaling in male Wistar rats with epilepsy. |
| Q42551361 | Pilocarpine-induced seizures are accompanied by a transient elevation in the messenger RNA expression of the prohormone convertase PC1 in rat hippocampus: comparison with nerve growth factor and brain-derived neurotrophic factor expression |
| Q42515771 | Pilocarpine-induced seizures cause selective time-dependent changes to adult-generated hippocampal dentate granule cells. |
| Q43505982 | Pilocarpine-induced status epilepticus causes N-methyl-D-aspartate receptor-dependent inhibition of microsomal Mg(2+)/Ca(2+) ATPase-mediated Ca(2+) uptake |
| Q42127111 | Pilocarpine-induced status epilepticus in mice: A comparison of spectral analysis of electroencephalogram and behavioral grading using the Racine scale |
| Q44017807 | Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice |
| Q72072564 | Possible involvement of the spinal substance P system in pilocarpine-induced scratching in mice |
| Q48480023 | Postictal alterations induced by intrahippocampal injection of pilocarpine in C57BL/6 mice. |
| Q34183008 | Proteomic profiling of the epileptic dentate gyrus |
| Q46650894 | Qualitative study of hippocampal formation in hypertensive rats with epilepsy |
| Q35198051 | Rapid throughput analysis demonstrates that chemicals with distinct seizurogenic mechanisms differentially alter Ca2+ dynamics in networks formed by hippocampal neurons in culture |
| Q34098055 | Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy |
| Q34072654 | Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy |
| Q43850180 | Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. |
| Q73676118 | Ricinine-elicited seizures. A novel chemical model of convulsive seizures |
| Q44416460 | Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activity |
| Q28377962 | Scopolamine-induced convulsions in food given fasted mice: effects of clonidine and tizanidine |
| Q42548060 | Scopolamine-induced convulsions in food given fasted mice: effects of physostigmine and MK-801. |
| Q48730385 | Seizure elements and seizure element transitions during tonic-clonic seizure activity in the synapsin I/II double knockout mouse: a neuroethological description |
| Q51705118 | Serotonin neurones have anti-convulsant effects and reduce seizure-induced mortality. |
| Q44066385 | Short-term effects of pilocarpine on rat hippocampal neurons in culture |
| Q92414401 | Single amyloid-beta injection exacerbates 4-aminopyridine-induced seizures and changes synaptic coupling in the hippocampus |
| Q28332791 | Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy |
| Q48846929 | Spontaneous seizures preferentially injure interneurons in the pilocarpine model of chronic spontaneous seizures |
| Q42548250 | Status epilepticus induced by pilocarpine and picrotoxin |
| Q44868458 | Status epilepticus results in an N-methyl-D-aspartate receptor-dependent inhibition of Ca2+/calmodulin-dependent kinase II activity in the rat. |
| Q35577639 | Strain differences in seizure-induced cell death following pilocarpine-induced status epilepticus |
| Q44975838 | Study of spontaneous recurrent seizures and morphological alterations after status epilepticus induced by intrahippocampal injection of pilocarpine. |
| Q42278938 | Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats |
| Q38011835 | Synaptic connections of hilar basal dendrites of dentate granule cells in a neonatal hypoxia model of epilepsy |
| Q50999445 | TRPC Channels and Epilepsy. |
| Q59488673 | Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus |
| Q48712886 | Temporally unstructured electrical stimulation to the amygdala suppresses behavioral chronic seizures of the pilocarpine animal model. |
| Q48552203 | The anticonvulsant and neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats |
| Q41893041 | The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo |
| Q44974509 | The impact of genetic background on neurodegeneration and behavior in seizured mice |
| Q30462810 | The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide |
| Q40463975 | The pilocarpine model of epilepsy |
| Q42553850 | The pilocarpine model of epilepsy in mice |
| Q37590175 | The pilocarpine model of epilepsy: what have we learned? |
| Q36841686 | The pilocarpine model of temporal lobe epilepsy |
| Q89891936 | The polarity and properties of radial glia-like neural stem cells are altered by seizures with status epilepticus: Study using an improved mouse pilocarpine model of epilepsy |
| Q34685588 | The promise of an interneuron-based cell therapy for epilepsy |
| Q37176694 | The role of dopamine signaling in epileptogenesis |
| Q44046080 | The role of muscarinic acetylcholine receptor-mediated activation of extracellular signal-regulated kinase 1/2 in pilocarpine-induced seizures. |
| Q38111374 | The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress |
| Q38262696 | The role of transcription factors cyclic-AMP responsive element modulator (CREM) and inducible cyclic-AMP early repressor (ICER) in epileptogenesis |
| Q43172852 | The sleep-wake cycle in adult rats following pilocarpine-induced temporal lobe epilepsy |
| Q45181504 | Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy |
| Q37920144 | Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? |
| Q46175397 | Up-regulation of D-serine might induce GABAergic neuronal degeneration in the cerebral cortex and hippocampus in the mouse pilocarpine model of epilepsy |
| Q30497593 | Upregulation of STREX splice variant of the large conductance Ca2+-activated potassium (BK) channel in a rat model of mesial temporal lobe epilepsy |
| Q34979494 | Validation of suitable reference genes for expression studies in different pilocarpine-induced models of mesial temporal lobe epilepsy. |
| Q48462802 | Variable electrobehavioral patterns during focal nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid |